Skip to content Skip to footer
Eloctate: Benefits, Reviews, Info, Side Effects!
Rx Details
Eloctate
Antihemophilic factor VIII (recombinant), Eloctate, Eloctate (recombinant), Eloctate (recombinant) injection
Antihemophilic factor VIII (recombinant), Fc fusion protein
Prescription
Medication
Drugs
Prescription Only
longer-lasting protection against bleeding episodes, reduced frequency of infusions, improved quality of life for hemophilia A patients, potential for personalized dosing regimens, support for joint health and mobility
Chills, Dizziness, Fever, Headache, Itching, Joint Pain, Nausea, Rash, Redness At The Injection Site, Vomiting
Eloctate is a recombinant factor VIII therapy used to treat and prevent bleeding in individuals with hemophilia A. The dosage of Eloctate is individualized based on the patient’s weight, the severity of factor VIII deficiency, the location and extent of bleeding, and the patient’s clinical condition. For routine prophylaxis, the typical dosage is 50 IU/kg administered every 3 to 5 days. However, some patients may require adjustments to this regimen based on their bleeding episodes and response to treatment. For on-demand treatment of bleeding episodes, the dosage and frequency depend on the severity of the bleed and the desired factor VIII level. It’s important for patients to follow their healthcare provider’s specific dosage recommendations and to have their factor VIII levels monitored regularly to ensure effective treatment.
Hemophilia a
Eloctate has a favorable safety profile.
No Interactions Reported
$1,000 – $5,000
$10,000 – $15,000 per vial

A Synopsis of

Eloctate

Eloctate is a medication that is used to treat and prevent bleeding episodes in individuals with hemophilia A. Hemophilia A is a genetic disorder that affects the blood’s ability to clot properly, leading to prolonged bleeding and easy bruising. Eloctate works by replacing the missing or deficient factor VIII in the blood, which is necessary for clotting to occur.

This medication is administered through intravenous infusion and is typically given on a regular schedule to prevent bleeding episodes. Eloctate has been shown to be effective in reducing the frequency of bleeding episodes in individuals with hemophilia A, allowing them to lead more active and normal lives.

It is important to follow your healthcare provider’s instructions carefully when taking Eloctate. They will determine the appropriate dosage and schedule for your specific needs. It is also important to report any unusual bleeding or bruising to your healthcare provider, as this may indicate a need for a dosage adjustment.

Like any medication, Eloctate may cause side effects in some individuals. Common side effects may include headache, nausea, and injection site reactions. If you experience any severe or persistent side effects, it is important to contact your healthcare provider immediately.

Overall, Eloctate is a valuable treatment option for individuals with hemophilia A, helping to prevent bleeding episodes and improve quality of life. If you have been prescribed Eloctate, be sure to discuss any questions or concerns with your healthcare provider to ensure safe and effective treatment.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN